Literature DB >> 6715506

Diabetes and hypercholesterolemia among patients with calcific aortic stenosis.

S Deutscher, H E Rockette, V Krishnaswami.   

Abstract

To help clarify the etiology and pathogenesis of calcific aortic stenosis, we studied retrospectively the relationship existing between that condition and two presumptive risk factors: diabetes and hypercholesterolemia. Fifty-four patients with isolated aortic stenosis, undergoing cardiac catheterization, were compared to patients without aortic stenosis who underwent angiography for unrelated reasons. The effect of diabetes and hypercholesterolemia, singly and in combination, upon the prevalence of aortic stenosis, was tested by various methods, including mathematical model fitting: Both study factors were found to be associated with aortic stenosis; their combined effect upon the prevalence of that disease appeared to be multiplicative. These findings suggest that diabetes and hypercholesterolemia may play a role in the causation of aortic stenosis. Further studies among unselected populations are needed to confirm the existence of the associations uncovered.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6715506     DOI: 10.1016/0021-9681(84)90108-5

Source DB:  PubMed          Journal:  J Chronic Dis        ISSN: 0021-9681


  20 in total

1.  Risk factors for progression of calcific aortic stenosis and potential therapeutic targets.

Authors:  Ashvin R Kamath; Ramdas G Pai
Journal:  Int J Angiol       Date:  2008

2.  Administration of angiotensin-converting enzyme inhibitors is associated with slow progression of mild aortic stenosis in Japanese patients.

Authors:  Kana Wakabayashi; Takeshi Tsujino; Yoshiro Naito; Akira Ezumi; Masaaki Lee-Kawabata; Shinji Nakao; Akiko Goda; Yasushi Sakata; Kazuhiro Yamamoto; Takashi Daimon; Tohru Masuyama
Journal:  Heart Vessels       Date:  2010-11-10       Impact factor: 2.037

Review 3.  Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update.

Authors:  Nalini M Rajamannan; Frank J Evans; Elena Aikawa; K Jane Grande-Allen; Linda L Demer; Donald D Heistad; Craig A Simmons; Kristyn S Masters; Patrick Mathieu; Kevin D O'Brien; Frederick J Schoen; Dwight A Towler; Ajit P Yoganathan; Catherine M Otto
Journal:  Circulation       Date:  2011-10-18       Impact factor: 29.690

4.  Minimally invasive surgery for valvular heart disease.

Authors:  Daniel G Cuadrado; Marzia Leacche; John G Byrne
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-12

5.  Medial arterial calcification and its association with mortality and complications of diabetes.

Authors:  J E Everhart; D J Pettitt; W C Knowler; F A Rose; P H Bennett
Journal:  Diabetologia       Date:  1988-01       Impact factor: 10.122

6.  A case-control investigation of the relation between hyperlipidaemia and calcific aortic valve stenosis.

Authors:  P T Wilmshurst; R N Stevenson; H Griffiths; J R Lord
Journal:  Heart       Date:  1997-11       Impact factor: 5.994

Review 7.  The role of Lrp5/6 in cardiac valve disease: LDL-density-pressure theory.

Authors:  Nalini M Rajamannan
Journal:  J Cell Biochem       Date:  2011-09       Impact factor: 4.429

8.  Association of aortic valve sclerosis and coronary artery disease in patients with severe nonischemic mitral regurgitation.

Authors:  Andrea Rossi; Gerald Bertagnolli; Mariantonietta Cicoira; Giorgio Golia; Luisa Zanolla; Francesco Santini; Claudio Cemin; Gabriele Ferrario; Piero Zardini
Journal:  Clin Cardiol       Date:  2003-12       Impact factor: 2.882

Review 9.  Mechanisms of aortic valve calcification: the LDL-density-radius theory: a translation from cell signaling to physiology.

Authors:  Nalini M Rajamannan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-10-23       Impact factor: 4.733

10.  ACE inhibition attenuates uremia-induced aortic valve thickening in a novel mouse model.

Authors:  Mikko A Simolin; Tanja X Pedersen; Susanne Bro; Mikko I Mäyränpää; Satu Helske; Lars B Nielsen; Petri T Kovanen
Journal:  BMC Cardiovasc Disord       Date:  2009-03-03       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.